Breast cancer is a major health problem for women around the world, including case study is as each year more than 502,000 women Because of the risk of this cancer will lose their lives. Breast cancer has ranked number one cancer among Indian and Iranian females. In this study enrolled two country patients, therefore prescription was analyzed for breast cancer, which showed that majority population was female. A retrospective analysis were done on breast cancer patients diagnosed for 2015 at the Cancer Research Centre of Shahid Beheshti University of Medical Sciences in Tehran, Iran and for India (PBCR (Population Based Cancer Registry) .we estimated the ASR for developing breast cancer among Iranian women at 17.1 per 100 000 person-years and for Indian females with age adjusted rate as high as 25.8 per100,000 women. The peak incidence rate for breast cancer were in the age group 45–54 years for both Iran and India. we excluded women with a diagnosis of benign lesion, intra lobular neoplasia, or intra ductal neoplasia. Intra ductal neoplasia represented the 17.6% of screen detected and the 14.4% of extra screening imaging-detected breast lesions, while it accounted for only the 2.5% of palpable lesions. Organized, invitational breast cancer screening in case study succeeded in detecting early-stage tumors, which have been consequently treated more frequently with breast and axillary conservative surgery, complementary breast irradiation, and eventual hormonal therapy. Age standardized incidence rates (ASR) of breast cancer in developed countries is nearly threefold higher than in developing countries. Iran and India have had one of the lowest incidence rates for breast cancer in the world, but during the last four decades increasing incidence rates of breast cancer made it the most prevalent cancer in Iranian and Indian women. After adjustment for age, Indian young women are at relatively higher risk of breast cancer than their counterparts in developed countries.
